Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640053 · ClinicalTrials.gov registry record · NA
Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome
A NA study, sponsored by Academic and Community Cancer Research United.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02640053 is a NA study that has completed, run by Academic and Community Cancer Research United. The registered enrollment target is 46 participants.
The verdict
NCT02640053, a NA study, has completed, sponsored by Academic and Community Cancer Research United.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies topical cryotherapy (cooling hands and feet with ice bags) in reducing pain in patients with chemotherapy induced peripheral neuropathy or paclitaxel induced acute pain syndrome. Peripheral neuropathy is a nerve problem that causes pain, numbness, tingling, swelling, or muscle weakness in different parts of the body. Paclitaxel produces a disabling syndrome of acute aches and pains. Topical cryotherapy is being studied to see if it can help relieve pain from peripheral neuropathy or acute pain syndrome caused by chemotherapy.
Interventions
- OTHER Quality-of-Life Assessment
- DRUG Paclitaxel
- OTHER Questionnaire Administration
- PROCEDURE Cryotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-12-23 |
| Est. Completion | 2018-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02640053
The ClinicalTrials.gov registry entry for NCT02640053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Academic and Community Cancer Research United, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02640053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02640053 about?
NCT02640053 is a clinical study titled "Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome". This randomized pilot clinical trial studies topical cryotherapy (cooling hands and feet with ice bags) in reducing pain in patients with chemotherapy induced peripheral neuropathy or paclitaxel induced acute pain syndrome. Peripheral neuropathy is a nerve problem that causes pain, numbness, tinglin...
What is the current status of trial NCT02640053?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2015-12-23. Estimated completion is 2018-10-05.
What interventions are being tested in trial NCT02640053?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Paclitaxel (DRUG), Questionnaire Administration (OTHER), Cryotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT02640053?
This trial is sponsored by Academic and Community Cancer Research United, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.